We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DVR
926
DELISTED
CAL DIVE INTERNATIONAL INC COM
DVR
| $3.67M | 0.01% |
2,781,181
-55,000
| -2% | -$80.9K |
2013 Q2
4 quarters
|
|
|
MCF
927
DELISTED
Contango Oil & Gas Co.
MCF
| $3.66M | 0.01% |
86,480
-7,000
| -7% | -$312K |
2013 Q2
4 quarters
|
|
|
DYAX
928
DELISTED
DYAX CORPORATION
DYAX
| $3.65M | 0.01% |
380,200
-105,400
| -22% | -$803K |
2013 Q2
4 quarters
|
|
929
Cineverse
CNVS
$39.9M
| $3.63M | 0.01% |
7,298
-1,200
| -14% | -$613K |
2013 Q2
4 quarters
|
|
930
ServisFirst Bancshares
SFBS
$4.33B
| $3.63M | 0.01% |
+504,000
| New | +$3.61M |
2014 Q2
0 quarters
|
|
931
CONMED
CNMD
$1.41B
| $3.63M | 0.01% |
82,200
| – | – |
2013 Q2
4 quarters
|
|
932
MaxLinear
MXL
$7.09B
| $3.61M | 0.01% |
+358,700
| New | +$3.29M |
2014 Q2
0 quarters
|
|
|
HGG
933
DELISTED
hhgregg Inc.
HGG
| $3.61M | 0.01% |
355,031
| – | – |
2013 Q2
4 quarters
|
|
|
LGTY
934
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $3.56M | 0.01% |
360,384
+110,500
| +44% | +$1.07M |
2013 Q2
4 quarters
|
|
|
IDXG
935
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $3.55M | 0.01% |
8,106
-745
| -8% | -$344K |
2013 Q2
4 quarters
|
|
936
Fiserv Inc
FISV
$25.1B
| $3.52M | 0.01% |
116,680
| – | – |
2013 Q2
4 quarters
|
|
937
LiveRamp
RAMP
$2.28B
| $3.51M | 0.01% |
162,000
| – | – |
2013 Q3
3 quarters
|
|
938
UTStarcom
UTSI
$22.7M
| $3.5M | 0.01% |
298,777
+19,325
| +7% | +$217K |
2013 Q2
4 quarters
|
|
939
Harvard Bioscience
HBIO
$37.8M
| $3.49M | 0.01% |
76,710
| – | – |
2013 Q2
4 quarters
|
|
940
Charles Schwab
SCHW
$163B
| $3.49M | 0.01% |
129,556
+21,200
| +20% | +$556K |
2013 Q2
4 quarters
|
|
|
JMBA
941
DELISTED
Jamba, Inc.
JMBA
| $3.48M | 0.01% |
287,330
-408,000
| -59% | -$4.56M |
2013 Q2
4 quarters
|
|
|
GLBR
942
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $3.44M | 0.01% |
+23,020
| New | +$3.31M |
2014 Q2
0 quarters
|
|
943
DELISTED
Navigant Consulting, Inc.
NCI
| $3.44M | 0.01% |
+196,900
| New | +$3.41M |
2014 Q2
0 quarters
|
|
944
Turtle Beach Corp
TBCH
$290M
| $3.42M | 0.01% |
92,675
+41,250
| +80% | +$1.7M |
2013 Q2
4 quarters
|
|
|
ANAD
945
DELISTED
ANADIGICS INC
ANAD
| $3.4M | 0.01% |
4,203,964
+730,000
| +21% | +$911K |
2013 Q2
4 quarters
|
|
946
NewMarket
NEU
$8.16B
| $3.38M | 0.01% |
8,626
-53,900
| -86% | -$20.8M |
2013 Q2
4 quarters
|
|
|
ZIXI
947
DELISTED
Zix Corporation
ZIXI
| $3.37M | 0.01% |
985,000
+100,000
| +11% | +$351K |
2013 Q2
4 quarters
|
|
948
HF Sinclair
DINO
$22.2B
| $3.34M | 0.01% |
76,400
-23,200
| -23% | -$1.14M |
2013 Q2
4 quarters
|
|
949
Primis Financial Corp
FRST
$383M
| $3.33M | 0.01% |
298,645
+10,000
| +3% | +$104K |
2013 Q2
4 quarters
|
|
950
Comp X International
CIX
$460M
| $3.33M | 0.01% |
318,600
| – | – |
2013 Q2
4 quarters
|
|
Similar funds
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.